Stay updated on Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page.

Latest updates to the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history, reflecting a system release update on this page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry (Revision: v3.3.3) was added to the history, and an older revision (v3.3.2) along with the HHS Vulnerability Disclosure item were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedThe Record History shows a new Revision: v3.3.2 entry. The previous Revision: v3.2.0 entry is removed.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved a government funding/operating status notice banner. The trial record history and study details remain unchanged.SummaryDifference0.7%

- Check81 days agoChange DetectedA new version on 2024-03-17 adds a recruitment status update. The history shows the study was terminated and will not proceed to Phase II, with prior status updates documented.SummaryDifference0.1%

- Check110 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference12%

Stay in the know with updates to Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page.